These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model. Durgan K; Ali M; Warner P; Latchman YE Cancer Immunol Immunother; 2011 Apr; 60(4):547-58. PubMed ID: 21240487 [TBL] [Abstract][Full Text] [Related]
5. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223 [TBL] [Abstract][Full Text] [Related]
6. Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. Maazi H; Singh AK; Speak AO; Lombardi V; Lam J; Khoo B; Inn KS; Sharpe AH; Jung JU; Akbari O PLoS One; 2013; 8(3):e59599. PubMed ID: 23555047 [TBL] [Abstract][Full Text] [Related]
7. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ. Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738 [TBL] [Abstract][Full Text] [Related]
8. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437 [TBL] [Abstract][Full Text] [Related]
9. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma. Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361 [TBL] [Abstract][Full Text] [Related]
10. Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response. Gu T; Zhu YB; Chen C; Li M; Chen YJ; Yu GH; Ge Y; Zhou SY; Zhou H; Huang Y; Qiu YH; Zhang XG Cell Mol Immunol; 2008 Feb; 5(1):33-9. PubMed ID: 18318992 [TBL] [Abstract][Full Text] [Related]
11. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716 [TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. Parekh VV; Lalani S; Kim S; Halder R; Azuma M; Yagita H; Kumar V; Wu L; Kaer LV J Immunol; 2009 Mar; 182(5):2816-26. PubMed ID: 19234176 [TBL] [Abstract][Full Text] [Related]
13. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097 [TBL] [Abstract][Full Text] [Related]
14. Blockade of CD40L inhibits immunogenic maturation of lung dendritic cells: Implications for the role of lung iNKT cells in mouse models of asthma. Deng N; Chen Q; Guo X; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Zhao Y; Chen X; Nie H Mol Immunol; 2020 May; 121():167-185. PubMed ID: 32229377 [TBL] [Abstract][Full Text] [Related]
15. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes. Tohn R; Blumenfeld H; Haeryfar SM; Veerapen N; Besra GS; Porcelli SA; Delovitch TL Clin Exp Immunol; 2011 Apr; 164(1):26-41. PubMed ID: 21361909 [TBL] [Abstract][Full Text] [Related]